Company intelligence / Profile preview

Byers Capital

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Byers Capital is an active family office investor specializing in early-stage investments, especially in biotechnology, longevity, and AI/healthtech companies; it does not have its own clinical pipeline but backs multiple innovative clinical and health-related ventures.

Industry: Investors

Partnerships

NeuralinkNewLimitBenchlingVialFreenome

Beyond the preview

Go deeper on Byers Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Byers Capital.

Explore the full profile